Testing Drugs and Testing Limits: Merck KGaA v. Integra Lifesciences I, Ltd. and the Scope of the Hatch-Waxman Safe Harbor Provision
2006-05
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Testing Drugs and Testing Limits: Merck KGaA v. Integra Lifesciences I, Ltd. and the Scope of the Hatch-Waxman Safe Harbor Provision
Authors
Published Date
2006-05
Publisher
University of Minnesota. Consortium on Law and Values in Health, Environment & the Life Sciences
Type
Article
Abstract
Keywords
Description
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Minnesota Journal of Law, Science & Technology, Volume 7, Issue 2 (May 2006), pages 713-756.
Other identifiers
Suggested citation
Hareid, Jonathan A.. (2006). Testing Drugs and Testing Limits: Merck KGaA v. Integra Lifesciences I, Ltd. and the Scope of the Hatch-Waxman Safe Harbor Provision. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/155981.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.